ENTRY       D08866                      Drug
NAME        Baminercept (USAN/INN);
            Baminercept alfa (USAN)
FORMULA     C4074H6282N1134O1274S68
EXACT_MASS  93650.2648
MOL_WEIGHT  93710.7243
SEQUENCE    AVPPYASENQ TCRDQEKEYY EPQHRICCSR CPPGTYVSAK CSRIRDTVCA TCAENSYNEH
            WNYLTICQLC RPCDPVMGLE EIAPCTSKRK TQCRCQPGMF CAAWALECTH CELLSDCPPG
            TEAELKDEVG KGNNHCVPCK AGHFQNTSSP SARCQPHTRC ENQGLVEAAP GTAQSDTTCK
            NPLEPLPPEM SGTMVDKTHT CPPCPAPELL GGPSVFLFPP KPKDTLMISR TPEVTCVVVD
            VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN
            KALPAPIEKT ISKAKGQPRE PQVYTLPPSR DELTKNQVSL TCLVKGFYPS DIAVEWESNG
            QPENNYKTTP PVLDSDGSFF LYSKLTVDKS RWQQGNVFSC SVMHEALHNH YTQKSLSLSP
            G
            (Disulfide bridge: 12-27, 28-41, 31-49, 52-67, 70-85, 73-93, 95-101, 108-117, 111-136, 139-154, 160-179, 236-296, 342-400, 201-201', 204-204')
  TYPE      Peptide
EFFICACY    Anti-inflammatory, TNF inhibitor
COMMENT     Fusion protein
            Treatment of rheumatoid arthritis
TARGET      LTB (TNFC, TNFSF3) [HSA:4050] [KO:K03157]
  PATHWAY   hsa04060(4050)  Cytokine-cytokine receptor interaction
            hsa04064(4050)  NF-kappa B signaling pathway
            hsa05323(4050)  Rheumatoid arthritis
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                LTB (TNFC, TNFSF3)
                 D08866  Baminercept (USAN/INN)
DBLINKS     CAS: 909110-25-4
            PubChem: 96025549
///
